Amgen (Germany) Investor Sentiment

AMG Stock  EUR 254.30  1.30  0.51%   
About 54% of Amgen's investor base is interested to short. The analysis of current outlook of investing in Amgen Inc suggests that many traders are impartial regarding Amgen's prospects. The current market sentiment, together with Amgen's historical and current headlines, can help investors time the market. In addition, many technical investors use Amgen Inc stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Amgen Inc. stock rises Tuesday, still underperforms market - MarketWatch
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Will Benefit From Increased Medical Spending - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Amgen Down 6.5 percent Since Last Earnings Report Can It Rebound - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Mariner LLC Purchases 109078 Shares of Amgen Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Heres Why Were Wary Of Buying Amgens For Its Upcoming Dividend - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Is Amgen Stock a Buy Now - The Motley Fool
Google News at Macroaxis
over six months ago at news.google.com         
Syon Capital LLC Purchases New Position in Amgen Inc. - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
JJ beats profit estimates on pharmaceutical unit strength - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Bremer Bank National Association Acquires 10589 Shares of Amgen Inc. - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Amgen Stock Moves -0.15 percent What You Should Know - Zacks Investment Research
Google News at Macroaxis
over a year ago at news.google.com         
FDA Rejects Amgens NDA Seeking Full Nod for Lumakras - Zacks Investment Research
Google News at Macroaxis
over a year ago at news.google.com         
Amgen upgraded by BMO on underappreciated opportunity in obesitymetabolic space - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Is Amgen Stock a Buy Now - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Amgen names former Novartis exec James Bradner as chief scientific officer - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Amgen Inc. Shares Sold by Great West Life ... - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Amgen that are available to investors today. That information is available publicly through Amgen media outlets and privately through word of mouth or via Amgen internal channels. However, regardless of the origin, that massive amount of Amgen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amgen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amgen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amgen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amgen alpha.

Amgen Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years